Treatment of chronic hepatitis C relapse
Olivé, G.; Buti, M.; Esteban-Mur, R.; Guardia, J.
Gastroenterologia y Hepatologia 23(Suppl 1): 47-50
2000
ISSN/ISBN: 0210-5705 PMID: 11968344 Document Number: 513370
Document emailed within 1 workday
Related Documents
Da Silva, L.C.; Mattar, E.; Carrilho, F.J.; Takeda, A.; Sette Júnior, H.; Gayotto, L.C. 1983: Disappearance of hepatitis B surface antigen in chronic type B hepatitis after clinical and laboratorial relapse produced by abrupt withdrawal of immunosuppressive drugs Revista do Instituto de Medicina Tropical de Sao Paulo 25(6): 270-274Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Golledge, C. 1995: Chronic diarrhoea with relapse after treatment Australian Family Physician 24(4): 659
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Takami, A.; Chuhjo, T.; Nakao, S. 2002: Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen Haematologica 87(6): 659-661
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Pirotte, J.; Rauber, G.; Ruyters, L. 1972: Chronic persistent hepatitis and chronic active hepatitis. Correlations between the histological aspects, clinical picture, biological and immunological data Archives Francaises des Maladies de l'Appareil Digestif 61(1): 7-18
Sonnabend, W.; Kistler, G.S.; Thiel, G.; Zollinger, H.U.; Bianchi, L.; Enderlin, F.; Gudat, F.; Krech, U. 1974: Chronic focal glomerulonephritis and chronic persistent hepatitis following kidney transplantation. Detection of Hepatitis B and Epstein-Barr virus antigen Schweizerische Medizinische Wochenschrift 104(35): 1205-1217
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Forns Bernhardt, X. 2000: Treatment of chronic hepatitis C. Combined treatment in naive patients Gastroenterologia y Hepatologia 23(Suppl 1): 43-46
Amarapurkar, D. 2007: Role of liver biopsy in management of chronic hepatitis B and chronic hepatitis C Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 28(2): 67-68
Marcellin, P.; Asselah, T.; Ripault, M.P.; Boyer, N. 2004: Treatment of chronic hepatitis c Minerva Gastroenterologica E Dietologica 50(1): 29-36
Labayle, D.; Chapaut, J.C.; Etienne, J.P. 1978: Chronic hepatitis and its treatment La Revue du Praticien 35(25): 1915-1924
García-Tsao, G. 1995: Treatment of chronic hepatitis C Revista de Gastroenterologia de Mexico 60(4 Suppl 2: S52-S53
Asselah, T.; Lada, O.; Marcellin, P. 2011: Treatment of chronic hepatitis B La Revue du Praticien 61(1): 45-51